WO2009111709A2 - Balloon catheter devices with solvent-swellable polymer - Google Patents

Balloon catheter devices with solvent-swellable polymer Download PDF

Info

Publication number
WO2009111709A2
WO2009111709A2 PCT/US2009/036349 US2009036349W WO2009111709A2 WO 2009111709 A2 WO2009111709 A2 WO 2009111709A2 US 2009036349 W US2009036349 W US 2009036349W WO 2009111709 A2 WO2009111709 A2 WO 2009111709A2
Authority
WO
WIPO (PCT)
Prior art keywords
polymer
balloon
solvent
styrene
block copolymers
Prior art date
Application number
PCT/US2009/036349
Other languages
French (fr)
Other versions
WO2009111709A3 (en
Inventor
John Chen
Original Assignee
Boston Scientific Scimed, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Scientific Scimed, Inc. filed Critical Boston Scientific Scimed, Inc.
Priority to EP09717854A priority Critical patent/EP2262547B1/en
Publication of WO2009111709A2 publication Critical patent/WO2009111709A2/en
Publication of WO2009111709A3 publication Critical patent/WO2009111709A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M25/1027—Making of balloon catheters
    • A61M25/1029—Production methods of the balloon members, e.g. blow-moulding, extruding, deposition or by wrapping a plurality of layers of balloon material around a mandril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08—Materials for coatings
    • A61L29/085—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0043—Catheters; Hollow probes characterised by structural features
    • A61M2025/0056—Catheters; Hollow probes characterised by structural features provided with an antibacterial agent, e.g. by coating, residing in the polymer matrix or releasing an agent out of a reservoir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M25/1027—Making of balloon catheters
    • A61M25/1029—Production methods of the balloon members, e.g. blow-moulding, extruding, deposition or by wrapping a plurality of layers of balloon material around a mandril
    • A61M2025/1031—Surface processing of balloon members, e.g. coating or deposition; Mounting additional parts onto the balloon member's surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M2025/1043—Balloon catheters with special features or adapted for special applications
    • A61M2025/105—Balloon catheters with special features or adapted for special applications having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0043—Catheters; Hollow probes characterised by structural features
    • A61M25/0045—Catheters; Hollow probes characterised by structural features multi-layered, e.g. coated
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2009/00—Layered products
    • B29L2009/005—Layered products coated

Definitions

  • the present invention relates to medical devices, more particularly, to catheter devices.
  • Catheters are used in a wide variety of minimally-invasive or percutaneous medical procedures.
  • Balloon catheters having drug coatings may be used to treat diseased portions of blood vessels.
  • the balloon is inserted through a peripheral blood vessel and then guided via a catheter through the vascular system to the target intravascular site.
  • the flow of blood may wash away some of the drug coating.
  • the control of the timing, location and/or duration of the release of the drug can be an issue. Therefore, there is a need for improved catheter-based devices for drug delivery to an intravascular site.
  • the present invention provides a method for making a medical device, comprising: providing a balloon, wherein a wall of the balloon or a coating over the balloon comprises a polymer, wherein the polymer is swellable in an organic solvent; exposing said polymer to a mixture of said solvent and a therapeutic agent; and removing the solvent.
  • FIGS. IA and IB show a catheter device according to an embodiment of the present invention.
  • FIG. IA shows the catheter device with the balloon in a deflated state.
  • FIG. IB shows the catheter device with the balloon in an inflated state.
  • FIGS. 2A-2C schematically illustrate a polymer matrix in a balloon wall or a balloon coating according to an embodiment of the present invention.
  • FIG. 2 A shows the polymer matrix prior to solvent exposure.
  • FIG. 2B shows the polymer matrix in an expanded condition after exposure to a mixture of a solvent and a therapeutic agent.
  • FIG. 2C shows the polymer matrix in a contracted condition after the removal of the solvent.
  • Catheter devices of the present invention use an expandable balloon for delivering a therapeutic agent to a target site in the body.
  • the balloon is designed to be insertable in the body via a catheter.
  • the therapeutic agent can be associated with the balloon in any of various ways, as further described below. Any of various mechanisms conventionally used for the delivery, actuation, or expansion (e.g., by inflation) of balloon catheter devices may be used in the present invention.
  • the balloon catheter may be designed similar to those that have been known in the art, including but not limited to angioplasty catheters, stent delivery catheters, inflation catheters and/or perfusion catheters.
  • the catheter devices of the present invention may be used in conjunction with other drug delivery devices, such as stents.
  • a balloon catheter 20 comprises a catheter body 22 having a balloon 24 mounted thereon.
  • the balloon In FIG. IA, the balloon is in a deflated state; in FIG. IB, the balloon is in an inflated state.
  • the body of the balloon can be single-layered or multiple-layered.
  • a balloon comprises a solvent-swellable polymer.
  • the solvent-swellable polymer may have a therapeutic agent incorporated therein and may be used to form a wall of the balloon or to form a coating disposed over the balloon.
  • the polymer is swellable upon exposure to an organic solvent.
  • the organic solvent can be polar or non-polar.
  • the organic solvent has a low boiling point.
  • the organic solvent has a boiling point of about 9O 0 C or less, about 8O 0 C or less, or about 7O 0 C or less. Solvents with low boiling points can be removed relatively easier than those with high boiling points.
  • Non- limiting examples of organic solvents include dichloromethane, chloroform, carbon tetrachloride, ethyl acetate, tetrahydrofuran, acetonitrile, hexane, and cyclohexane.
  • the solvent-swellable polymer is a semi-crystalline polymer.
  • the semi- crystalline polymer can form a polymer matrix having crystalline portions and amorphous portions.
  • the solvent and the therapeutic agent diffuses into and swells preferentially the amorphous regions of the polymer matrix.
  • the crystalline portions of the polymer matrix are more resistant to swelling, and therefore form a stable structure that maintains the physical structure of the polymer-containing balloon wall or coating.
  • the solvent is removed, the polymer matrix contracts to its original conformation, entrapping the therapeutic agent within the polymer matrix.
  • a catheter device comprises a balloon comprising a solvent-swellable, semi-crystalline polymer.
  • FIG. 2A shows a polymer matrix 70 on the wall of the balloon prior to solvent exposure.
  • Polymer matrix 70 has crystalline regions 72, which are represented schematically by the lines, and amorphous regions 74, which are represented schematically by the spaces.
  • FIG. 2B upon exposure to a mixture of a solvent and a therapeutic agent, amorphous regions 74 absorb the solvent and therapeutic agent 76, causing polymer matrix 70 to swell.
  • FIG. 2C upon removal of the solvent, polymer matrix 70 contracts to its original conformation such that therapeutic agent 76 is retained within polymer matrix 70.
  • the solvent-swellable polymer is a partially cross-linked polymer.
  • the cross-linking density is low to allow at least a portion of the polymer to swell in an organic solvent.
  • the cross-linking can be done using any known methods.
  • the cross-linking may be induced by UV irradiation or electron beam irradiation.
  • the cross-linked portions of the polymer serve as the stable structure, while the non-crosslinked portions of the polymer swell upon exposure to an organic solvent and entrap the therapeutic agent previously mixed with the solvent after the solvent is removed.
  • the solvent-swellable polymer is grafted onto the surface of the balloon through chemical bonding.
  • the balloon wall base itself serves as the stable structure, while the polymer swells upon exposure to an organic solvent and entraps the therapeutic agent previously mixed with the solvent after the solvent is removed.
  • Non-limiting examples of solvent-swellable polymers include block copolymers of styrene-ethylene/butylene-styrene (“SEBS”), block copolymers of styrene-ethylene/propylene- styrene (“SEPS”), block copolymers of styrene-butadiene-styrene (“SBS”), block copolymers of styrene-isoprene-styrene (“SIS”), polyolefins such as polyethylene and polypropylene, polyurethane, polyoxymethylene-acetyl copolymers, polyamide block copolymers, and copolymers of acrylates and methacrylates.
  • SEBS styrene-ethylene/butylene-styrene
  • SEPS styrene-ethylene/propylene- styrene
  • SBS block copolymers of styrene-butadiene-s
  • the SEBS, SEPS, SBS, and SIS copolymers can be commercially-available copolymers, such as those sold under the trade names KRATON G and KRATON D.
  • the solvent- swellable polymer has unsaturated bonds to allow for cross-linking or grafting.
  • the solvent may be removed by any known method, for example, evaporation or vacuum drying.
  • the solvent is removed without heating.
  • the solvent is removed by evaporation.
  • the balloon comprising a therapeutic agent-containing polymer is inserted into the body and delivered to the target site.
  • the balloon is then inflated, causing the polymer (in the case of a semi-crystalline polymer being used, polymer matrix 70) in the balloon wall to undergo expansion by mechanical force.
  • the therapeutic agent e.g. therapeutic agent 76
  • the therapeutic agent is released from the wall of the balloon. Because the therapeutic agent is preferably loaded through diffusion, it tends to locate near the surface of the wall or coating and can be easily released after the balloon catheter device is delivered to the target site.
  • Medical devices of the present invention may also include a vascular stent mounted on the balloon.
  • the vascular stent may be any of those known in the art, including those with or without coatings that contain a therapeutic agent.
  • the stent may also be biostable, bioerodable, or biodegradable.
  • the balloons of the present invention may also be coated with a low-molecular weight carbohydrate, such as mannitol.
  • the carbohydrate may be a separate coating or be blended with the therapeutic agent.
  • the balloons of the present invention may also be coated with a radiocontrast agent (ionic or non-ionic), such as iopromide.
  • the contrast agent may be a separate coating or be blended with the therapeutic agent.
  • the therapeutic agent used in the present invention may be any pharmaceutically acceptable agent (such as a drug), a biomolecule, a small molecule, or cells.
  • Example drugs include anti-proliferative agents or anti-restenosis agents such as paclitaxel, sirolimus (rapamycin), tacrolimus, everolimus, and zotarolimus.
  • Other example drugs include those that are anti-spasmodic agents and vasodilators.
  • Example biomolecules include peptides, polypeptides and proteins; antibodies; oligonucleotides; nucleic acids such as double or single stranded DNA (including naked and cDNA), RNA, antisense nucleic acids such as antisense DNA and RNA, small interfering RNA (siRNA), and ribozymes; genes; carbohydrates; angiogenic factors including growth factors; cell cycle inhibitors; and anti-restenosis agents.
  • Example small molecules include hormones, nucleotides, amino acids, sugars, and lipids and compounds have a molecular weight of less than 10OkD.
  • Example cells include stem cells, progenitor cells, endothelial cells, adult cardiomyocytes, and smooth muscle cells.
  • a double-layered balloon is manufactured.
  • the inner layer is made of high density polyethylene and the outer layer is made of SEBS (KRATON G, Kraton Polymers, Houston, TX).
  • SEBS KRATON G, Kraton Polymers, Houston, TX.
  • the SEBS in the outer layer is crosslinked by electron beam irradiation.
  • the balloon is then immersed in a mixture of cyclohexane and paclitaxel for drug loading. After the balloon is taken out, the cyclohexane is removed by evaporation. The balloon is then assembled onto a balloon catheter device.

Abstract

Methods for making a balloon catheter device comprising a solvent-swellable polymer are provided. The method includes providing a balloon, wherein a wall of the balloon or a coating over the balloon comprises a polymer, wherein the polymer is swellable in an organic solvent. In certain embodiments of the invention, the polymer on the balloon is exposed to a mixture of said solvent and a therapeutic agent; and the solvent is thereafter removing, leaving the therapeutic agent in the polymer.

Description

12013/87276
BALLOON CATHETER DEVICES WITH SOLVENT-SWELLABLE POLYMER
RELATED APPLICATIONS
[0001] This application claims the benefit of provisional application Serial No. 61/034,328, filed March 6, 2008, which is incorporated herein by reference in its entirety.
TECHNICAL FIELD
[0002] The present invention relates to medical devices, more particularly, to catheter devices.
BACKGROUND
[0003] Catheters are used in a wide variety of minimally-invasive or percutaneous medical procedures. Balloon catheters having drug coatings may be used to treat diseased portions of blood vessels. Typically, the balloon is inserted through a peripheral blood vessel and then guided via a catheter through the vascular system to the target intravascular site. However, as the balloon travels through the vascular system, the flow of blood may wash away some of the drug coating. In addition, the control of the timing, location and/or duration of the release of the drug can be an issue. Therefore, there is a need for improved catheter-based devices for drug delivery to an intravascular site.
SUMMARY
[0004] In one embodiment, the present invention provides a method for making a medical device, comprising: providing a balloon, wherein a wall of the balloon or a coating over the balloon comprises a polymer, wherein the polymer is swellable in an organic solvent; exposing said polymer to a mixture of said solvent and a therapeutic agent; and removing the solvent.
BRIEF DESCRIPTION OF THE DRAWINGS
[0005] FIGS. IA and IB show a catheter device according to an embodiment of the present invention. FIG. IA shows the catheter device with the balloon in a deflated state. FIG. IB shows the catheter device with the balloon in an inflated state.
[0006] FIGS. 2A-2C schematically illustrate a polymer matrix in a balloon wall or a balloon coating according to an embodiment of the present invention. FIG. 2 A shows the polymer matrix prior to solvent exposure. FIG. 2B shows the polymer matrix in an expanded condition after exposure to a mixture of a solvent and a therapeutic agent. FIG. 2C shows the polymer matrix in a contracted condition after the removal of the solvent.
DETAILED DESCRIPTION
[0007] Catheter devices of the present invention use an expandable balloon for delivering a therapeutic agent to a target site in the body. The balloon is designed to be insertable in the body via a catheter. The therapeutic agent can be associated with the balloon in any of various ways, as further described below. Any of various mechanisms conventionally used for the delivery, actuation, or expansion (e.g., by inflation) of balloon catheter devices may be used in the present invention. The balloon catheter may be designed similar to those that have been known in the art, including but not limited to angioplasty catheters, stent delivery catheters, inflation catheters and/or perfusion catheters. The catheter devices of the present invention may be used in conjunction with other drug delivery devices, such as stents.
[0008] Referring to FIGS. IA and IB, in certain embodiments, a balloon catheter 20 comprises a catheter body 22 having a balloon 24 mounted thereon. In FIG. IA, the balloon is in a deflated state; in FIG. IB, the balloon is in an inflated state. The body of the balloon can be single-layered or multiple-layered.
[0009] In one aspect of the present invention, a balloon comprises a solvent-swellable polymer. The solvent-swellable polymer may have a therapeutic agent incorporated therein and may be used to form a wall of the balloon or to form a coating disposed over the balloon.
[0010] Preferably, the polymer is swellable upon exposure to an organic solvent. The organic solvent can be polar or non-polar. Preferably, the organic solvent has a low boiling point. Preferably, the organic solvent has a boiling point of about 9O0C or less, about 8O0C or less, or about 7O0C or less. Solvents with low boiling points can be removed relatively easier than those with high boiling points. Non- limiting examples of organic solvents include dichloromethane, chloroform, carbon tetrachloride, ethyl acetate, tetrahydrofuran, acetonitrile, hexane, and cyclohexane.
[0011] Optionally, the solvent-swellable polymer is a semi-crystalline polymer. The semi- crystalline polymer can form a polymer matrix having crystalline portions and amorphous portions. When the polymer matrix is exposed to a mixture of a suitable organic solvent and a therapeutic agent, the solvent and the therapeutic agent diffuses into and swells preferentially the amorphous regions of the polymer matrix. The crystalline portions of the polymer matrix are more resistant to swelling, and therefore form a stable structure that maintains the physical structure of the polymer-containing balloon wall or coating. When the solvent is removed, the polymer matrix contracts to its original conformation, entrapping the therapeutic agent within the polymer matrix.
[0012] For example, referring to the schematic illustration shown in FIGS. 2A-2C, a catheter device comprises a balloon comprising a solvent-swellable, semi-crystalline polymer. FIG. 2A shows a polymer matrix 70 on the wall of the balloon prior to solvent exposure. Polymer matrix 70 has crystalline regions 72, which are represented schematically by the lines, and amorphous regions 74, which are represented schematically by the spaces. Referring to FIG. 2B, upon exposure to a mixture of a solvent and a therapeutic agent, amorphous regions 74 absorb the solvent and therapeutic agent 76, causing polymer matrix 70 to swell. Referring to FIG. 2C, upon removal of the solvent, polymer matrix 70 contracts to its original conformation such that therapeutic agent 76 is retained within polymer matrix 70.
[0013] Optionally, the solvent-swellable polymer is a partially cross-linked polymer. Preferably, the cross-linking density is low to allow at least a portion of the polymer to swell in an organic solvent. The cross-linking can be done using any known methods. For example, the cross-linking may be induced by UV irradiation or electron beam irradiation. The cross-linked portions of the polymer serve as the stable structure, while the non-crosslinked portions of the polymer swell upon exposure to an organic solvent and entrap the therapeutic agent previously mixed with the solvent after the solvent is removed.
[0014] Optionally, the solvent-swellable polymer is grafted onto the surface of the balloon through chemical bonding. In this case, the balloon wall base itself serves as the stable structure, while the polymer swells upon exposure to an organic solvent and entraps the therapeutic agent previously mixed with the solvent after the solvent is removed.
[0015] Non-limiting examples of solvent-swellable polymers include block copolymers of styrene-ethylene/butylene-styrene ("SEBS"), block copolymers of styrene-ethylene/propylene- styrene ("SEPS"), block copolymers of styrene-butadiene-styrene ("SBS"), block copolymers of styrene-isoprene-styrene ("SIS"), polyolefins such as polyethylene and polypropylene, polyurethane, polyoxymethylene-acetyl copolymers, polyamide block copolymers, and copolymers of acrylates and methacrylates. The SEBS, SEPS, SBS, and SIS copolymers can be commercially-available copolymers, such as those sold under the trade names KRATON G and KRATON D. Preferably, the solvent- swellable polymer has unsaturated bonds to allow for cross-linking or grafting.
[0016] After the therapeutic agent is loaded into the polymer, the solvent may be removed by any known method, for example, evaporation or vacuum drying. Preferably, the solvent is removed without heating. Preferably, the solvent is removed by evaporation.
[0017] In operation, the balloon comprising a therapeutic agent-containing polymer is inserted into the body and delivered to the target site. The balloon is then inflated, causing the polymer (in the case of a semi-crystalline polymer being used, polymer matrix 70) in the balloon wall to undergo expansion by mechanical force. By enlarging the space within the polymer (e.g. polymer matrix 70), the therapeutic agent (e.g. therapeutic agent 76) is released from the wall of the balloon. Because the therapeutic agent is preferably loaded through diffusion, it tends to locate near the surface of the wall or coating and can be easily released after the balloon catheter device is delivered to the target site.
[0018] Medical devices of the present invention may also include a vascular stent mounted on the balloon. The vascular stent may be any of those known in the art, including those with or without coatings that contain a therapeutic agent. The stent may also be biostable, bioerodable, or biodegradable.
[0019] The balloons of the present invention may also be coated with a low-molecular weight carbohydrate, such as mannitol. The carbohydrate may be a separate coating or be blended with the therapeutic agent. The balloons of the present invention may also be coated with a radiocontrast agent (ionic or non-ionic), such as iopromide. The contrast agent may be a separate coating or be blended with the therapeutic agent.
[0020] The therapeutic agent used in the present invention may be any pharmaceutically acceptable agent (such as a drug), a biomolecule, a small molecule, or cells. Example drugs include anti-proliferative agents or anti-restenosis agents such as paclitaxel, sirolimus (rapamycin), tacrolimus, everolimus, and zotarolimus. Other example drugs include those that are anti-spasmodic agents and vasodilators. Example biomolecules include peptides, polypeptides and proteins; antibodies; oligonucleotides; nucleic acids such as double or single stranded DNA (including naked and cDNA), RNA, antisense nucleic acids such as antisense DNA and RNA, small interfering RNA (siRNA), and ribozymes; genes; carbohydrates; angiogenic factors including growth factors; cell cycle inhibitors; and anti-restenosis agents. Example small molecules include hormones, nucleotides, amino acids, sugars, and lipids and compounds have a molecular weight of less than 10OkD. Example cells include stem cells, progenitor cells, endothelial cells, adult cardiomyocytes, and smooth muscle cells.
Example 1
[0021] A double-layered balloon is manufactured. The inner layer is made of high density polyethylene and the outer layer is made of SEBS (KRATON G, Kraton Polymers, Houston, TX). The SEBS in the outer layer is crosslinked by electron beam irradiation. The balloon is then immersed in a mixture of cyclohexane and paclitaxel for drug loading. After the balloon is taken out, the cyclohexane is removed by evaporation. The balloon is then assembled onto a balloon catheter device.
[0022] The foregoing description and examples have been set forth merely to illustrate the invention and are not intended to be limiting. Each of the disclosed aspects and embodiments of the present invention may be considered individually or in combination with other aspects, embodiments, and variations of the invention. Modifications of the disclosed embodiments incorporating the spirit and substance of the invention may occur to persons skilled in the art and such modifications are within the scope of the present invention.

Claims

CLAIMSWe claim:
1. A method for making a medical device, comprising: providing a balloon, wherein a wall of the balloon or a coating over the balloon comprises a polymer, wherein the polymer is swellable in an organic solvent; exposing said polymer on the balloon to a mixture of said solvent and a therapeutic agent; and removing the solvent.
2. The method of claim 1 , wherein a wall of the balloon comprises the polymer swellable in an organic solvent.
3. The method of claim 1 , wherein a coating over the balloon comprises the polymer swellable in an organic solvent.
4. The method of claim 3, wherein the polymer is grafted to a wall of the balloon through chemical bonding.
5. The method of claim 1, wherein the polymer is a semi-crystalline polymer comprising crystalline regions and amorphous regions.
6. The method of claim 1, wherein the polymer is partially cross-linked.
7. The method of claim 1 , wherein the polymer is selected from the group consisting of block copolymers of styrene-ethylene/butylene-styrene, block copolymers of styrene- ethylene/propylene-styrene, block copolymers of styrene-butadiene, block copolymers of styrene-isoprene, polyolefϊns, polyurethane, polyoxymethylene-acetyl copolymers, polyamide block copolymers, copolymers of acrylates and methacrylates, and mixtures thereof.
8. The method of claim 7, wherein the polymer is selected from the group consisting of block copolymers of styrene-ethylene/butylene-styrene, block copolymers of styrene- ethylene/propylene-styrene, block copolymers of styrene-butadiene, block copolymers of styrene-isoprene, polyurethane, and mixtures thereof.
9. The method of claim 1 , wherein the solvent is a polar organic solvent.
10. The method of claim 1 , wherein the solvent is a non-polar organic solvent.
11. The method of claim 1 , wherein the boiling point of the solvent is about 9O0C or less.
12. The method of claim 1, wherein the solvent is selected from the group consisting of dichloromethane, chloroform, carbon tetrachloride, ethyl acetate, tetrahydrofuran, acetonitrile, hexane, cyclohexane, and mixtures thereof.
13. The method of claim 1 , wherein the solvent is removed by evaporation.
14. The method of claim 1 , wherein the therapeutic agent is selected from the group consisting of paclitaxel, sirolimus, tacrolimus, everolimus, zotarolimus, and mixtures thereof.
15. A method of releasing a therapeutic agent from the surface of a balloon catheter comprising: providing a balloon, wherein a wall of the balloon or a coating over the balloon comprises a polymer, wherein the polymer is swellable in an organic solvent; exposing said polymer on the balloon to a mixture of said solvent and a therapeutic agent; removing the solvent; and expanding the balloon to release the therapeutic agent.
16. The method of claim 15, wherein the polymer is grafted to a wall of the balloon through chemical bonding.
17. The method of claim 15, wherein the polymer is a semi-crystalline polymer comprising crystalline regions and amorphous regions.
18. The method of claim 15, wherein the polymer is partially cross-linked.
19. The method of claim 15, wherein the boiling point of the solvent is about 9O0C or less.
20. The method of claim 15, wherein the solvent is removed by evaporation.
PCT/US2009/036349 2008-03-06 2009-03-06 Balloon catheter devices with solvent-swellable polymer WO2009111709A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP09717854A EP2262547B1 (en) 2008-03-06 2009-03-06 Balloon catheter devices with solvent-swellable polymer

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3432808P 2008-03-06 2008-03-06
US61/034,328 2008-03-06

Publications (2)

Publication Number Publication Date
WO2009111709A2 true WO2009111709A2 (en) 2009-09-11
WO2009111709A3 WO2009111709A3 (en) 2010-07-08

Family

ID=40578099

Family Applications (3)

Application Number Title Priority Date Filing Date
PCT/US2009/036349 WO2009111709A2 (en) 2008-03-06 2009-03-06 Balloon catheter devices with solvent-swellable polymer
PCT/US2009/036354 WO2009111712A1 (en) 2008-03-06 2009-03-06 Balloon catheter devices with folded balloons
PCT/US2009/036359 WO2009111716A1 (en) 2008-03-06 2009-03-06 Balloon catheter devices with sheath covering

Family Applications After (2)

Application Number Title Priority Date Filing Date
PCT/US2009/036354 WO2009111712A1 (en) 2008-03-06 2009-03-06 Balloon catheter devices with folded balloons
PCT/US2009/036359 WO2009111716A1 (en) 2008-03-06 2009-03-06 Balloon catheter devices with sheath covering

Country Status (5)

Country Link
US (5) US8114049B2 (en)
EP (4) EP2262565A1 (en)
JP (2) JP2011513005A (en)
CA (1) CA2716985A1 (en)
WO (3) WO2009111709A2 (en)

Families Citing this family (156)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8177743B2 (en) 1998-05-18 2012-05-15 Boston Scientific Scimed, Inc. Localized delivery of drug agents
AU2006270221B2 (en) 2005-07-15 2012-01-19 Micell Technologies, Inc. Polymer coatings containing drug powder of controlled morphology
US20090062909A1 (en) 2005-07-15 2009-03-05 Micell Technologies, Inc. Stent with polymer coating containing amorphous rapamycin
CA2625264C (en) 2005-10-13 2015-12-15 Synthes (U.S.A.) Drug-impregnated sleeve for a medical implant
EP3150236B1 (en) * 2006-02-09 2018-12-26 B. Braun Melsungen AG Coating method for a folded balloon
ES2540059T3 (en) 2006-04-26 2015-07-08 Micell Technologies, Inc. Coatings containing multiple drugs
US20070282306A1 (en) * 2006-06-05 2007-12-06 Twincath, Llc Multi-lumen catheter with protected tip
US7777399B2 (en) * 2006-07-31 2010-08-17 Boston Scientific Scimed, Inc. Medical balloon incorporating electroactive polymer and methods of making and using the same
US9539593B2 (en) 2006-10-23 2017-01-10 Micell Technologies, Inc. Holder for electrically charging a substrate during coating
US8153181B2 (en) 2006-11-14 2012-04-10 Boston Scientific Scimed, Inc. Medical devices and related methods
US8430055B2 (en) 2008-08-29 2013-04-30 Lutonix, Inc. Methods and apparatuses for coating balloon catheters
US8414526B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids
US8998846B2 (en) 2006-11-20 2015-04-07 Lutonix, Inc. Drug releasing coatings for balloon catheters
US20080276935A1 (en) 2006-11-20 2008-11-13 Lixiao Wang Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
US9700704B2 (en) 2006-11-20 2017-07-11 Lutonix, Inc. Drug releasing coatings for balloon catheters
US9737640B2 (en) 2006-11-20 2017-08-22 Lutonix, Inc. Drug releasing coatings for medical devices
US8414525B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
US8425459B2 (en) * 2006-11-20 2013-04-23 Lutonix, Inc. Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent
US8414910B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
US20080175887A1 (en) 2006-11-20 2008-07-24 Lixiao Wang Treatment of Asthma and Chronic Obstructive Pulmonary Disease With Anti-proliferate and Anti-inflammatory Drugs
US11426494B2 (en) 2007-01-08 2022-08-30 MT Acquisition Holdings LLC Stents having biodegradable layers
US9737642B2 (en) 2007-01-08 2017-08-22 Micell Technologies, Inc. Stents having biodegradable layers
NZ588816A (en) 2007-01-21 2011-11-25 Hemoteq Ag Medical device for the treatment of stenoses of corporal lumina and for the prevention of impending restenoses
AU2008256684B2 (en) 2007-05-25 2012-06-14 Micell Technologies, Inc. Polymer films for medical device coating
US9192697B2 (en) 2007-07-03 2015-11-24 Hemoteq Ag Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis
WO2009061787A1 (en) * 2007-11-05 2009-05-14 Nanocopoeia, Inc. Coated devices and method of making coated devices that reduce smooth muscle cell proliferation and platelet activity
EP2262565A1 (en) * 2008-03-06 2010-12-22 Boston Scientific Scimed, Inc. Balloon catheter devices with sheath covering
US9480826B2 (en) 2008-03-21 2016-11-01 Cagent Vascular, Llc Intravascular device
US11219750B2 (en) 2008-03-21 2022-01-11 Cagent Vascular, Inc. System and method for plaque serration
CA2718067C (en) 2008-03-21 2014-07-08 Innovasc Llc Device and method for opening blood vessels by pre-angioplasty serration and dilatation of atherosclerotic plaque
DK2268332T3 (en) * 2008-04-09 2019-05-06 Aachen Scient International Pte Ltd PROCEDURE FOR PRODUCING A BIOACTIVE SURFACE ON AN ENDOPROSTESE OR ON THE BALLON OF A BALLON CATHET
CA2721832C (en) 2008-04-17 2018-08-07 Micell Technologies, Inc. Stents having bioabsorbable layers
EP3159033B1 (en) 2008-05-01 2019-02-27 Bayer Intellectual Property GmbH Catheter balloon drug adherence techniques and methods
US9539381B2 (en) * 2008-05-12 2017-01-10 Humparkull, Llc Hemostatic devices and methods for use thereof
US10426483B2 (en) 2008-05-12 2019-10-01 Mitchell R. Humphreys Hemostatic devices and methods for use thereof
JP2011528275A (en) 2008-07-17 2011-11-17 ミセル テクノロジーズ，インク． Drug delivery medical device
US9510856B2 (en) 2008-07-17 2016-12-06 Micell Technologies, Inc. Drug delivery medical device
US8968239B2 (en) * 2008-09-02 2015-03-03 Jose E. Herrera Catheter device for the dynamic regulation of the venous return to the heart for the treatment of patients with heart failure
US8128951B2 (en) * 2008-09-15 2012-03-06 Cv Ingenuity Corp. Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
US9198968B2 (en) 2008-09-15 2015-12-01 The Spectranetics Corporation Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
US8257722B2 (en) * 2008-09-15 2012-09-04 Cv Ingenuity Corp. Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
US8114429B2 (en) 2008-09-15 2012-02-14 Cv Ingenuity Corp. Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
WO2010080575A2 (en) 2008-12-18 2010-07-15 Michal Konstantino Method and apparatus for transport of substances into body tissue
US8834913B2 (en) 2008-12-26 2014-09-16 Battelle Memorial Institute Medical implants and methods of making medical implants
CN102481195B (en) 2009-04-01 2015-03-25 米歇尔技术公司 Drug delivery medical device
US8740843B2 (en) * 2009-04-13 2014-06-03 Cook Medical Technologies Llc Coated balloon catheter
EP3366326A1 (en) 2009-04-17 2018-08-29 Micell Technologies, Inc. Stents having controlled elution
EP2243501A1 (en) * 2009-04-24 2010-10-27 Eurocor Gmbh Shellac and paclitaxel coated catheter balloons
US20100285085A1 (en) * 2009-05-07 2010-11-11 Abbott Cardiovascular Systems Inc. Balloon coating with drug transfer control via coating thickness
WO2011005421A2 (en) 2009-07-10 2011-01-13 Boston Scientific Scimed, Inc. Use of nanocrystals for a drug delivery balloon
EP2453938B1 (en) 2009-07-17 2015-08-19 Boston Scientific Scimed, Inc. Nucleation of drug delivery balloons to provide improved crystal size and density
JP5767226B2 (en) * 2009-08-27 2015-08-19 ボストン サイエンティフィック サイムド，インコーポレイテッドＢｏｓｔｏｎ Ｓｃｉｅｎｔｉｆｉｃ Ｓｃｉｍｅｄ，Ｉｎｃ． Medical device
US20120232640A1 (en) 2009-11-19 2012-09-13 Blue Medical Devices Bv Narrow profile composition-releasing expandable medical balloon catheter
WO2011091100A1 (en) 2010-01-21 2011-07-28 Boston Scientific Scimed, Inc. Balloon catheters with therapeutic agent in balloon folds and methods of making the same
WO2011097103A1 (en) 2010-02-02 2011-08-11 Micell Technologies, Inc. Stent and stent delivery system with improved deliverability
US9199066B2 (en) 2010-03-12 2015-12-01 Quattro Vascular Pte Ltd. Device and method for compartmental vessel treatment
US8795762B2 (en) 2010-03-26 2014-08-05 Battelle Memorial Institute System and method for enhanced electrostatic deposition and surface coatings
WO2011133655A1 (en) 2010-04-22 2011-10-27 Micell Technologies, Inc. Stents and other devices having extracellular matrix coating
US10285568B2 (en) * 2010-06-03 2019-05-14 The General Hospital Corporation Apparatus and method for devices for imaging structures in or at one or more luminal organs
US20110301565A1 (en) * 2010-06-07 2011-12-08 Boston Scientific Scimed, Inc. Medical balloons having a sheath designed to facilitate release of therapeutic agent
US10596355B2 (en) 2010-06-30 2020-03-24 Surmodics, Inc. Catheter assembly
CA2805631C (en) 2010-07-16 2018-07-31 Micell Technologies, Inc. Drug delivery medical device
WO2012026717A2 (en) * 2010-08-25 2012-03-01 (주)이화바이오메딕스 Balloon catheter in which film for drug delivery is provided
EP2611476B1 (en) 2010-09-02 2016-08-10 Boston Scientific Scimed, Inc. Coating process for drug delivery balloons using heat-induced rewrap memory
US10780251B2 (en) * 2010-09-17 2020-09-22 W. L. Gore & Associates, Inc. Expandable medical devices
US8961457B2 (en) * 2010-09-30 2015-02-24 Surmodics, Inc. Catheter assembly with guard
CA2821728A1 (en) 2010-12-16 2012-06-21 Ams Research Corporation Micro-needle bladder balloon
US9724729B2 (en) * 2010-12-22 2017-08-08 Abbott Laboratories Method of modifying a coating on a medical device
US9415193B2 (en) * 2011-03-04 2016-08-16 W. L. Gore & Associates, Inc. Eluting medical devices
US9061127B2 (en) * 2011-04-29 2015-06-23 Boston Scientific Scimed, Inc. Protective surfaces for drug-coated medical devices
US8795228B2 (en) * 2011-05-05 2014-08-05 Boston Scientific Scimed, Inc. Drug delivery device with sheath for improved drug delivery
WO2012166819A1 (en) 2011-05-31 2012-12-06 Micell Technologies, Inc. System and process for formation of a time-released, drug-eluting transferable coating
US9370643B2 (en) * 2011-06-23 2016-06-21 W.L. Gore & Associates, Inc. High strength balloon cover
US10016579B2 (en) * 2011-06-23 2018-07-10 W.L. Gore & Associates, Inc. Controllable inflation profile balloon cover apparatus
US20220032015A1 (en) * 2011-06-23 2022-02-03 W. L. Gore & Associates, Inc. Controllable inflation profile balloon cover methods
US9370647B2 (en) 2011-07-14 2016-06-21 W. L. Gore & Associates, Inc. Expandable medical devices
US10117972B2 (en) 2011-07-15 2018-11-06 Micell Technologies, Inc. Drug delivery medical device
US20130030406A1 (en) 2011-07-26 2013-01-31 Medtronic Vascular, Inc. Textured Dilatation Balloon and Methods
WO2013022458A1 (en) 2011-08-05 2013-02-14 Boston Scientific Scimed, Inc. Methods of converting amorphous drug substance into crystalline form
WO2013028208A1 (en) 2011-08-25 2013-02-28 Boston Scientific Scimed, Inc. Medical device with crystalline drug coating
US9730726B2 (en) 2011-10-07 2017-08-15 W. L. Gore & Associates, Inc. Balloon assemblies having controllably variable topographies
US10188772B2 (en) 2011-10-18 2019-01-29 Micell Technologies, Inc. Drug delivery medical device
TWI590843B (en) 2011-12-28 2017-07-11 信迪思有限公司 Films and methods of manufacture
DE102012001188A1 (en) * 2012-01-24 2013-07-25 Qualimed Innovative Medizinprodukte Gmbh balloon catheter
WO2013114201A1 (en) 2012-02-01 2013-08-08 Tanhum Feld Device for compartmental dilatation of blood vessels
SG11201403915XA (en) 2012-02-08 2014-08-28 Quattro Vascular Pte Ltd Constraining structure with non-linear axial struts
US9216033B2 (en) * 2012-02-08 2015-12-22 Quattro Vascular Pte Ltd. System and method for treating biological vessels
CN104245038B (en) * 2012-03-09 2017-05-31 明讯科技有限公司 The medical sacculus of the radiation impermeable part with common extrusion
US20150110719A1 (en) * 2012-05-08 2015-04-23 Health Line International Corp. Hydrogel based delivery and sensor
US9878132B2 (en) 2012-06-15 2018-01-30 W. L. Gore & Associates, Inc. Vascular occlusion and drug delivery devices, systems, and methods
US9956385B2 (en) 2012-06-28 2018-05-01 The Spectranetics Corporation Post-processing of a medical device to control morphology and mechanical properties
JP6162932B2 (en) * 2012-06-29 2017-07-12 フクダ電子株式会社 Balloon catheter and balloon catheter manufacturing method
US9901715B2 (en) * 2012-09-05 2018-02-27 W. L. Gore Associates, Inc. Retractable sheath devices, systems, and methods
US11504450B2 (en) 2012-10-26 2022-11-22 Urotronic, Inc. Drug-coated balloon catheters for body lumens
CN104936629A (en) 2012-10-26 2015-09-23 优敦力公司 Drug coated balloon catheters for nonvascular strictures
US10881839B2 (en) 2012-10-26 2021-01-05 Urotronic, Inc. Drug-coated balloon catheters for body lumens
US10898700B2 (en) 2012-10-26 2021-01-26 Urotronic, Inc. Balloon catheters for body lumens
US10806830B2 (en) 2012-10-26 2020-10-20 Urotronic, Inc. Drug-coated balloon catheters for body lumens
US10850076B2 (en) 2012-10-26 2020-12-01 Urotronic, Inc. Balloon catheters for body lumens
US11938287B2 (en) 2012-10-26 2024-03-26 Urotronic, Inc. Drug-coated balloon catheters for body lumens
US10010654B2 (en) 2012-10-30 2018-07-03 W. L. Gore & Associates, Inc. Sleeve for medical device assembly
WO2014100030A1 (en) * 2012-12-18 2014-06-26 California Institute Of Technology Drug-eluting angioplasty balloon systems
US20140243846A1 (en) * 2013-02-26 2014-08-28 Cook Medical Technologies Llc Balloon Catheter and Method of Use Thereof
WO2014133708A1 (en) * 2013-02-26 2014-09-04 Cook Medical Technologies Llc Balloon catheter
AU2014248508B2 (en) 2013-03-12 2018-11-08 Micell Technologies, Inc. Bioabsorbable biomedical implants
US9669194B2 (en) 2013-03-14 2017-06-06 W. L. Gore & Associates, Inc. Conformable balloon devices and methods
JP6090852B2 (en) * 2013-04-02 2017-03-08 テルモ株式会社 Balloon catheter
CN105307716B (en) * 2013-05-03 2021-09-14 C·R·巴德公司 Strippable protective sleeve
JP2016519965A (en) 2013-05-15 2016-07-11 マイセル・テクノロジーズ，インコーポレイテッド Bioabsorbable biomedical implant
CN105555328B (en) 2013-06-21 2019-01-11 德普伊新特斯产品公司 film and manufacturing method
WO2015103097A1 (en) * 2014-01-02 2015-07-09 Boston Scientific Scimed, Inc. Drug eluting balloon with preferred drug orientation to improve drug transfer efficiency
US10525171B2 (en) 2014-01-24 2020-01-07 The Spectranetics Corporation Coatings for medical devices
WO2015187872A1 (en) 2014-06-04 2015-12-10 Cagent Vascular, Llc Cage for medical balloon
US20150367112A1 (en) * 2014-06-20 2015-12-24 Daniel Gelbart Medical Balloon with Reduced Straightening Force
JP5758029B1 (en) * 2014-06-25 2015-08-05 日出夫 文山 Body fluid flow non-blocking balloon catheter
LT3200860T (en) * 2014-10-02 2021-05-10 Aachen Scientific International Pte. Ltd. Cutback method for intravascular dilation catheter
CA2965376A1 (en) * 2014-10-22 2016-04-28 Jmd Innovation Inc. Anti-adhesion intrauterine balloon
WO2016073511A1 (en) * 2014-11-03 2016-05-12 Cagent Vascular, Llc Medical balloon
CN107405475B (en) 2014-11-03 2020-09-15 开金血管有限公司 Sawtooth air bag
US10232148B2 (en) 2014-11-17 2019-03-19 TriReme Medical, LLC Balloon catheter system and method of using same
CN104436421B (en) * 2014-11-28 2017-12-01 刘宗军 One kind can dabbling drug sacculus
KR101663805B1 (en) 2014-12-03 2016-10-14 연세대학교 산학협력단 Balloon Catheter Having Micro Needles and Manufacturing Method Thereof
CA2974376A1 (en) * 2015-01-22 2016-07-28 Intersect Ent, Inc. Drug-coated balloon
US11904072B2 (en) 2015-04-24 2024-02-20 Urotronic, Inc. Drug coated balloon catheters for nonvascular strictures
EP3285820A4 (en) 2015-04-24 2018-12-12 Urotronic, Inc. Drug coated balloon catheters for nonvascular strictures
EP3103501A1 (en) * 2015-06-12 2016-12-14 Arravasc Limited A drug coated angioplasty balloon
EP3326678A4 (en) 2015-07-22 2019-04-17 Olympus Corporation Endoscope treatment tool
US10166374B2 (en) 2015-09-17 2019-01-01 Cagent Vascular, Llc Wedge dissectors for a medical balloon
US10105519B2 (en) * 2015-10-20 2018-10-23 C.R. Bard, Inc. Variable diameter medical balloon
JP6788964B2 (en) * 2015-11-26 2020-11-25 フクダ電子株式会社 Catheter Balloon manufacturing method and balloon catheter
CN114225119A (en) * 2016-02-08 2022-03-25 祥丰医疗私人有限公司 Expandable balloon comprising a coating
US10792477B2 (en) * 2016-02-08 2020-10-06 Orbusneich Medical Pte. Ltd. Drug eluting balloon
EP3406294B1 (en) * 2016-03-23 2023-06-28 Terumo Kabushiki Kaisha Balloon catheter and production method therefor, and treatment method
JP6983156B2 (en) * 2016-07-04 2021-12-17 株式会社カネカ Balloon catheter
WO2018060466A1 (en) 2016-09-30 2018-04-05 Arravasc Limited Finned angioplasty balloon
US10874826B2 (en) 2016-10-05 2020-12-29 Terumo Corporation Balloon catheter systems
JP2018068724A (en) * 2016-10-31 2018-05-10 株式会社カネカ Balloon catheter
CN110114108B (en) 2016-11-16 2022-12-06 开金血管公司 System and method for depositing a drug into tissue through teeth
EP3546013A4 (en) * 2016-11-22 2020-09-02 Asahi Intecc Co., Ltd. Balloon catheter
EP3558408A1 (en) 2016-12-22 2019-10-30 Biotronik AG Intratumoral drug delivery materials and methods for treating breast cancer
JP2021036924A (en) * 2017-12-27 2021-03-11 テルモ株式会社 Balloon catheter
US10688287B2 (en) 2018-01-19 2020-06-23 Medtronic, Inc. Sheath including sheath body and sheath insert
US10737071B2 (en) 2018-01-19 2020-08-11 Medtronic, Inc. Splittable sheath
US10702673B2 (en) 2018-01-19 2020-07-07 Medtronic Vascular, Inc. Expandable balloon sheaths
US10682492B2 (en) 2018-01-19 2020-06-16 Medtronic Vascular, Inc. Expandable balloon sheath
US10668255B2 (en) 2018-01-19 2020-06-02 Medtronic Vascular, Inc. Sheath for medically expandable balloon
CN108187212B (en) * 2018-03-14 2022-07-15 董鹏 Medicine balloon
US10935149B2 (en) 2018-03-15 2021-03-02 University Of Washington Temperature-actuated valve, fluidic device, and related methods of use
WO2019182131A1 (en) * 2018-03-23 2019-09-26 テルモ株式会社 Medical device and method of applying medicament
JP2021530324A (en) 2018-07-25 2021-11-11 ケイジェント ヴァスキュラー， インコーポレイテッド Medical balloon catheter with improved push performance
US11389627B1 (en) 2018-10-02 2022-07-19 Lutonix Inc. Balloon protectors, balloon-catheter assemblies, and methods thereof
US11672959B2 (en) 2019-01-18 2023-06-13 Intersect Ent, Inc. Expandable member systems and methods for drug delivery
CN112089951A (en) * 2019-06-18 2020-12-18 微创神通医疗科技（上海）有限公司 Medical balloon, balloon catheter and medical device
WO2021161545A1 (en) * 2020-02-14 2021-08-19 日本ライフライン株式会社 Drug delivery balloon catheter
CN111298274B (en) * 2020-05-14 2020-09-22 上海脉全医疗器械有限公司 Medicine balloon and using method thereof
CN113350648A (en) * 2021-07-18 2021-09-07 温州医科大学附属第一医院 Tracheal catheter capable of accurately local anesthesia

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1462127A1 (en) * 1998-09-29 2004-09-29 Medtronic Vascular, Inc. Lubricious, drug-accommodating coating
US20080021385A1 (en) * 1997-08-13 2008-01-24 Scimed Life Systems, Inc. Loading and release of water-insoluble drugs

Family Cites Families (130)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4417576A (en) * 1982-02-25 1983-11-29 Baran Ostap E Double-wall surgical cuff
US4423725A (en) * 1982-03-31 1984-01-03 Baran Ostap E Multiple surgical cuff
SU1069826A1 (en) 1982-09-17 1984-01-30 Запорожский медицинский институт Endotracheal tube
US4748982A (en) * 1987-01-06 1988-06-07 Advanced Cardiovascular Systems, Inc. Reinforced balloon dilatation catheter with slitted exchange sleeve and method
US5042976A (en) * 1987-01-13 1991-08-27 Terumo Kabushiki Kaisha Balloon catheter and manufacturing method of the same
DE3821544C2 (en) * 1988-06-25 1994-04-28 H Prof Dr Med Just Dilatation catheter
US5749915A (en) * 1988-08-24 1998-05-12 Focal, Inc. Polymeric endoluminal paving process
DK170965B1 (en) * 1988-08-31 1996-04-09 Meadox Medicals Inc dilatation catheter
US5226913A (en) * 1988-09-01 1993-07-13 Corvita Corporation Method of making a radially expandable prosthesis
KR920000466B1 (en) * 1988-10-28 1992-01-14 간지 이노우에 Ballon catheter
US5091205A (en) * 1989-01-17 1992-02-25 Union Carbide Chemicals & Plastics Technology Corporation Hydrophilic lubricious coatings
US5015231A (en) * 1989-04-21 1991-05-14 Scimed Life Systems, Inc. Multipart split sleeve balloon protector for dilatation catheter
US4994033A (en) * 1989-05-25 1991-02-19 Schneider (Usa) Inc. Intravascular drug delivery dilatation catheter
US5843089A (en) * 1990-12-28 1998-12-01 Boston Scientific Corporation Stent lining
US5674192A (en) * 1990-12-28 1997-10-07 Boston Scientific Corporation Drug delivery
US5304121A (en) * 1990-12-28 1994-04-19 Boston Scientific Corporation Drug delivery system making use of a hydrogel polymer coating
US5049132A (en) * 1990-01-08 1991-09-17 Cordis Corporation Balloon catheter for delivering therapeutic agents
US5141494A (en) * 1990-02-15 1992-08-25 Danforth Biomedical, Inc. Variable wire diameter angioplasty dilatation balloon catheter
US5545208A (en) * 1990-02-28 1996-08-13 Medtronic, Inc. Intralumenal drug eluting prosthesis
US5092841A (en) * 1990-05-17 1992-03-03 Wayne State University Method for treating an arterial wall injured during angioplasty
US5190540A (en) * 1990-06-08 1993-03-02 Cardiovascular & Interventional Research Consultants, Inc. Thermal balloon angioplasty
US5499971A (en) * 1990-06-15 1996-03-19 Cortrak Medical, Inc. Method for iontophoretically delivering drug adjacent to a heart
US5498238A (en) * 1990-06-15 1996-03-12 Cortrak Medical, Inc. Simultaneous angioplasty and phoretic drug delivery
US5196024A (en) * 1990-07-03 1993-03-23 Cedars-Sinai Medical Center Balloon catheter with cutting edge
US5324261A (en) * 1991-01-04 1994-06-28 Medtronic, Inc. Drug delivery balloon catheter with line of weakness
US5893840A (en) * 1991-01-04 1999-04-13 Medtronic, Inc. Releasable microcapsules on balloon catheters
US5102402A (en) * 1991-01-04 1992-04-07 Medtronic, Inc. Releasable coatings on balloon catheters
WO1992019311A1 (en) * 1991-04-24 1992-11-12 Baxter International Inc. Exchangeable integrated-wire balloon catheter
US5195969A (en) * 1991-04-26 1993-03-23 Boston Scientific Corporation Co-extruded medical balloons and catheter using such balloons
US5213576A (en) * 1991-06-11 1993-05-25 Cordis Corporation Therapeutic porous balloon catheter
US5295959A (en) * 1992-03-13 1994-03-22 Medtronic, Inc. Autoperfusion dilatation catheter having a bonded channel
US5501662A (en) * 1992-05-22 1996-03-26 Genetronics, Inc. Implantable electroporation method and apparatus for drug and gene delivery
US5383928A (en) * 1992-06-10 1995-01-24 Emory University Stent sheath for local drug delivery
US5507724A (en) * 1992-07-01 1996-04-16 Genetronics, Inc. Electroporation and iontophoresis apparatus and method for insertion of drugs and genes into cells
DE4222380A1 (en) * 1992-07-08 1994-01-13 Ernst Peter Prof Dr M Strecker Endoprosthesis implantable percutaneously in a patient's body
US5447497A (en) * 1992-08-06 1995-09-05 Scimed Life Systems, Inc Balloon catheter having nonlinear compliance curve and method of using
US5348538A (en) * 1992-09-29 1994-09-20 Scimed Life Systems, Inc. Shrinking balloon catheter having nonlinear or hybrid compliance curve
US5352236A (en) * 1992-09-29 1994-10-04 Medtronic, Inc. Balloon protector
US5634901A (en) * 1992-11-02 1997-06-03 Localmed, Inc. Method of using a catheter sleeve
US5336178A (en) * 1992-11-02 1994-08-09 Localmed, Inc. Intravascular catheter with infusion array
US5807306A (en) * 1992-11-09 1998-09-15 Cortrak Medical, Inc. Polymer matrix drug delivery apparatus
JPH08507715A (en) * 1993-03-18 1996-08-20 シーダーズ サイナイ メディカル センター Drug-inducing and releasable polymeric coatings for bioartificial components
WO1994023787A1 (en) * 1993-04-22 1994-10-27 Rammler David H Sampling balloon catheter
US5464650A (en) * 1993-04-26 1995-11-07 Medtronic, Inc. Intravascular stent and method
DE4324218A1 (en) * 1993-07-19 1995-01-26 Bavaria Med Tech Cuff catheter
US6027779A (en) * 1993-08-18 2000-02-22 W. L. Gore & Associates, Inc. Thin-wall polytetrafluoroethylene tube
US5735892A (en) * 1993-08-18 1998-04-07 W. L. Gore & Associates, Inc. Intraluminal stent graft
US5746745A (en) * 1993-08-23 1998-05-05 Boston Scientific Corporation Balloon catheter
WO1995005860A1 (en) * 1993-08-23 1995-03-02 Boston Scientific Corporation Improved balloon catheter
US5738901A (en) * 1993-09-20 1998-04-14 Scimed Life Systems, Inc. Catheter balloon with retraction coating
US5397307A (en) * 1993-12-07 1995-03-14 Schneider (Usa) Inc. Drug delivery PTCA catheter and method for drug delivery
US5545132A (en) * 1993-12-21 1996-08-13 C. R. Bard, Inc. Helically grooved balloon for dilatation catheter and method of using
US5599306A (en) * 1994-04-01 1997-02-04 Localmed, Inc. Method and apparatus for providing external perfusion lumens on balloon catheters
US5456666A (en) * 1994-04-26 1995-10-10 Boston Scientific Corp Medical balloon folding into predetermined shapes and method
US5505700A (en) * 1994-06-14 1996-04-09 Cordis Corporation Electro-osmotic infusion catheter
US5601589A (en) * 1994-06-29 1997-02-11 General Surgical Innovations, Inc. Extraluminal balloon dissection apparatus and method
US5554120A (en) * 1994-07-25 1996-09-10 Advanced Cardiovascular Systems, Inc. Polymer blends for use in making medical devices including catheters and balloons for dilatation catheters
US5707385A (en) * 1994-11-16 1998-01-13 Advanced Cardiovascular Systems, Inc. Drug loaded elastic membrane and method for delivery
US5653689A (en) * 1995-09-30 1997-08-05 Abacus Design & Development, Inc. Infusion catheter
US6124007A (en) * 1996-03-06 2000-09-26 Scimed Life Systems Inc Laminate catheter balloons with additive burst strength and methods for preparation of same
EP0796633B1 (en) * 1996-03-18 2003-07-02 Hiroaki Ashiya Catheter assembly
US5707358A (en) * 1996-05-13 1998-01-13 Wright; John T. M. Dual concentric balloon catheter for retrograde cardioplegia perfusion
US5833659A (en) * 1996-07-10 1998-11-10 Cordis Corporation Infusion balloon catheter
US5868707A (en) * 1996-08-15 1999-02-09 Advanced Cardiovascular Systems, Inc. Protective sheath for catheter balloons
EP0835673A3 (en) 1996-10-10 1998-09-23 Schneider (Usa) Inc. Catheter for tissue dilatation and drug delivery
US5704908A (en) * 1996-10-10 1998-01-06 Genetronics, Inc. Electroporation and iontophoresis catheter with porous balloon
US5833651A (en) * 1996-11-08 1998-11-10 Medtronic, Inc. Therapeutic intraluminal stents
US5730734A (en) * 1996-11-14 1998-03-24 Scimed Life Systems, Inc. Catheter systems with interchangeable parts
US5866561A (en) * 1997-08-21 1999-02-02 Scimed Life Systems, Inc. Local delivery of estrogen for angiogenesis
US5928193A (en) * 1997-10-03 1999-07-27 Boston Scientific Corporation Balloon catheterization
US6364856B1 (en) * 1998-04-14 2002-04-02 Boston Scientific Corporation Medical device with sponge coating for controlled drug release
US6450989B2 (en) * 1998-04-27 2002-09-17 Artemis Medical, Inc. Dilating and support apparatus with disease inhibitors and methods for use
US8177743B2 (en) * 1998-05-18 2012-05-15 Boston Scientific Scimed, Inc. Localized delivery of drug agents
US6280411B1 (en) * 1998-05-18 2001-08-28 Scimed Life Systems, Inc. Localized delivery of drug agents
US6206283B1 (en) * 1998-12-23 2001-03-27 At&T Corp. Method and apparatus for transferring money via a telephone call
US6369039B1 (en) * 1998-06-30 2002-04-09 Scimed Life Sytems, Inc. High efficiency local drug delivery
US6652581B1 (en) * 1998-07-07 2003-11-25 Boston Scientific Scimed, Inc. Medical device with porous surface for controlled drug release and method of making the same
US6129706A (en) * 1998-12-10 2000-10-10 Janacek; Jaroslav Corrugated catheter balloon
US6593130B1 (en) * 1999-04-16 2003-07-15 The Regents Of The University Of California Method and apparatus for ex vivo and in vivo cellular electroporation of gene protein or drug therapy
JP2001009037A (en) 1999-06-25 2001-01-16 Terumo Corp Balloon for dilation of narrow segment and balloon catheter
DE19933279A1 (en) * 1999-07-14 2001-03-01 Biotronik Mess & Therapieg Polymer blend useful for medical instruments such as balloon catheters, comprises partially crystalline polyamide polymer and a polystyrene thermoplastic elastomer flexibilizing agent
US6733513B2 (en) * 1999-11-04 2004-05-11 Advanced Bioprosthetic Surfaces, Ltd. Balloon catheter having metal balloon and method of making same
CA2392006C (en) * 1999-11-17 2011-03-15 Microchips, Inc. Microfabricated devices for the delivery of molecules into a carrier fluid
US6544221B1 (en) * 2000-08-30 2003-04-08 Advanced Cardiovascular Systems, Inc. Balloon designs for drug delivery
US6638246B1 (en) * 2000-11-28 2003-10-28 Scimed Life Systems, Inc. Medical device for delivery of a biologically active material to a lumen
US6544223B1 (en) * 2001-01-05 2003-04-08 Advanced Cardiovascular Systems, Inc. Balloon catheter for delivering therapeutic agents
US6547803B2 (en) * 2001-09-20 2003-04-15 The Regents Of The University Of California Microfabricated surgical device for interventional procedures
US20030077310A1 (en) * 2001-10-22 2003-04-24 Chandrashekhar Pathak Stent coatings containing HMG-CoA reductase inhibitors
US6656155B2 (en) * 2001-12-17 2003-12-02 Scimed Life Systems, Inc. Catheter for endoluminal delivery of therapeutic agents that minimizes loss of therapeutic
US6743388B2 (en) * 2001-12-31 2004-06-01 Advanced Cardiovascular Systems, Inc. Process of making polymer articles
US7758605B2 (en) * 2002-02-28 2010-07-20 Boston Scientific Scimed, Inc. Balloon folding apparatus, methods and products
US20040127978A1 (en) * 2002-08-13 2004-07-01 Medtronic, Inc. Active agent delivery system including a hydrophilic polymer, medical device, and method
US6991617B2 (en) * 2002-08-21 2006-01-31 Hektner Thomas R Vascular treatment method and device
DE10244847A1 (en) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medical device for drug delivery
US7048714B2 (en) * 2002-10-30 2006-05-23 Biorest Ltd. Drug eluting medical device with an expandable portion for drug release
WO2004060471A1 (en) 2003-01-02 2004-07-22 Novoste Corporation Drug delivery balloon catheter
US7081113B2 (en) * 2003-06-26 2006-07-25 Depuy Acromed, Inc. Helical probe
US8025637B2 (en) * 2003-07-18 2011-09-27 Boston Scientific Scimed, Inc. Medical balloons and processes for preparing same
US7364585B2 (en) * 2003-08-11 2008-04-29 Boston Scientific Scimed, Inc. Medical devices comprising drug-loaded capsules for localized drug delivery
US7166099B2 (en) * 2003-08-21 2007-01-23 Boston Scientific Scimed, Inc. Multilayer medical devices
WO2005027996A2 (en) 2003-09-15 2005-03-31 Atrium Medical Corporation Application of a therapeutic substance to a tissue location using an expandable medical device
WO2005037339A1 (en) 2003-10-14 2005-04-28 Cube Medical A/S A balloon for use in angioplasty
JP4443278B2 (en) 2004-03-26 2010-03-31 テルモ株式会社 Catheter with expansion body
US20050228417A1 (en) * 2004-03-26 2005-10-13 Teitelbaum George P Devices and methods for removing a matter from a body cavity of a patient
WO2005105171A1 (en) * 2004-04-29 2005-11-10 Cube Medical A/S A balloon for use in angioplasty with an outer layer of nanofibers
WO2005113058A1 (en) 2004-05-21 2005-12-01 Medtronic Vascular Inc. Folded balloon for catheter
US20050273049A1 (en) * 2004-06-08 2005-12-08 Peter Krulevitch Drug delivery device using microprojections
US20070299392A1 (en) * 2004-07-14 2007-12-27 By-Pass, Inc. Material Delivery System
US20060025848A1 (en) * 2004-07-29 2006-02-02 Jan Weber Medical device having a coating layer with structural elements therein and method of making the same
US7491188B2 (en) 2004-10-12 2009-02-17 Boston Scientific Scimed, Inc. Reinforced and drug-eluting balloon catheters and methods for making same
US20060127442A1 (en) * 2004-12-09 2006-06-15 Helmus Michael N Use of supercritical fluids to incorporate biologically active agents into nanoporous medical articles
US8202245B2 (en) * 2005-01-26 2012-06-19 Boston Scientific Scimed, Inc. Medical devices and methods of making the same
US8048028B2 (en) * 2005-02-17 2011-11-01 Boston Scientific Scimed, Inc. Reinforced medical balloon
US8672990B2 (en) * 2005-05-27 2014-03-18 Boston Scientific Scimed, Inc. Fiber mesh controlled expansion balloon catheter
US8795348B2 (en) 2005-06-14 2014-08-05 Boston Scientific Scimed, Inc. Medical devices and related methods
WO2007053728A1 (en) * 2005-11-01 2007-05-10 Cook Incorporated Angioplasty cutting device and method
US20070112300A1 (en) 2005-11-14 2007-05-17 Roman Ricardo D Balloon folding design, apparatus and method of making the same
US20070184085A1 (en) * 2006-02-03 2007-08-09 Boston Scientific Scimed, Inc. Ultrasound activated medical device
EP3150236B1 (en) * 2006-02-09 2018-12-26 B. Braun Melsungen AG Coating method for a folded balloon
US20070191811A1 (en) 2006-02-10 2007-08-16 Joseph Berglund System and Method for Treating a Vascular Condition
US7572625B2 (en) * 2006-05-18 2009-08-11 Boston Scientific Scimed, Inc. Medical devices coated with drug carrier macromolecules
US20080097300A1 (en) 2006-08-07 2008-04-24 Sherif Eskaros Catheter balloon with multiple micropleats
US20080033476A1 (en) * 2006-08-07 2008-02-07 Greene Joel M Catheter balloon with controlled failure sheath
US20080140002A1 (en) 2006-12-06 2008-06-12 Kamal Ramzipoor System for delivery of biologically active substances with actuating three dimensional surface
NZ588816A (en) 2007-01-21 2011-11-25 Hemoteq Ag Medical device for the treatment of stenoses of corporal lumina and for the prevention of impending restenoses
US9370642B2 (en) 2007-06-29 2016-06-21 J.W. Medical Systems Ltd. Adjustable-length drug delivery balloon
US20090105687A1 (en) 2007-10-05 2009-04-23 Angioscore, Inc. Scoring catheter with drug delivery membrane
EP2262565A1 (en) 2008-03-06 2010-12-22 Boston Scientific Scimed, Inc. Balloon catheter devices with sheath covering
EP2106820A1 (en) 2008-03-31 2009-10-07 Torsten Heilmann Expansible biocompatible coats comprising a biologically active substance
JP5767226B2 (en) * 2009-08-27 2015-08-19 ボストン サイエンティフィック サイムド，インコーポレイテッドＢｏｓｔｏｎ Ｓｃｉｅｎｔｉｆｉｃ Ｓｃｉｍｅｄ，Ｉｎｃ． Medical device

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080021385A1 (en) * 1997-08-13 2008-01-24 Scimed Life Systems, Inc. Loading and release of water-insoluble drugs
EP1462127A1 (en) * 1998-09-29 2004-09-29 Medtronic Vascular, Inc. Lubricious, drug-accommodating coating

Also Published As

Publication number Publication date
WO2009111716A1 (en) 2009-09-11
US20090227948A1 (en) 2009-09-10
US20120053517A1 (en) 2012-03-01
EP2262547A2 (en) 2010-12-22
EP2262547B1 (en) 2013-01-09
WO2009111709A3 (en) 2010-07-08
US20090226502A1 (en) 2009-09-10
JP2011513004A (en) 2011-04-28
EP2262566A1 (en) 2010-12-22
US20110270226A1 (en) 2011-11-03
JP2011513005A (en) 2011-04-28
US20090227949A1 (en) 2009-09-10
US8114049B2 (en) 2012-02-14
EP2594311A3 (en) 2013-07-10
CA2716985A1 (en) 2009-09-11
EP2594311A2 (en) 2013-05-22
EP2262565A1 (en) 2010-12-22
WO2009111712A1 (en) 2009-09-11

Similar Documents

Publication Publication Date Title
EP2262547B1 (en) Balloon catheter devices with solvent-swellable polymer
US20200237971A1 (en) Delivery of hydrophobic active agent particles
US8652200B2 (en) Medical devices comprising drug-loaded capsules for localized drug delivery
CN101795719B (en) Stent for controlled drug release
JP5210635B2 (en) Endoluminal treatment patch
US10213529B2 (en) Delivery of coated hydrophobic active agent particles
US20110178503A1 (en) Balloon catheters with therapeutic agent in balloon folds and methods of making the same
US9227041B2 (en) Balloon catheters with fibers for delivery of therapeutic agent and methods of making the same
US8889211B2 (en) Coating process for drug delivery balloons using heat-induced rewrap memory
US20120150142A1 (en) Drug Eluting Balloons with Ability for Double Treatment
EP2427227A2 (en) Balloon coating with drug transfer control via coating thickness
CN105214143A (en) For sending the apparatus and method of bioactivator
US10898446B2 (en) Delivery of hydrophobic active agents from hydrophilic polyether block amide copolymer surfaces
EP2178578A2 (en) Medical devices comprising polymeric drug delivery systems with drug solubility gradients
WO2006055237A2 (en) Therapeutic driving layer for a medical device
WO2005097224A1 (en) Polymer-coated stent
JP6668131B2 (en) Balloon catheter, manufacturing method and treatment method thereof
WO2008127966A1 (en) Photoresist coating to apply a coating to select areas of a medical device
JPWO2018169052A1 (en) Manufacturing method of balloon catheter
WO2023079290A1 (en) Drug coated balloon

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09717854

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2009717854

Country of ref document: EP